I noticed the company lodged a relatively recent patent application (became public this year, I found it using Patentscope). Its for a diagnostic method, and seems to represent an improvement on the existing one. Its hard to tell how novel it is without referring to the current patents. I expect one can procure these, but I havent done so. I dont suppose anyone has?
Certainly, measuring cell-mediated immunity (ie Quantiferon) has many potential applications (actually, they are listed in the aforementioned document) and they are not totally pie-in-the-sky. Theres a reasonable evidence base in the research literature already for the role of cell-mediated immunity in certain conditions and measuring humoral immunity (ie the first arm of the adaptive immune response) is long established as a tool in diagnostic medicine.
One would assume that CST are exploring other possibilities for their technology, but its impossible to know how close on the horizon these might be commercially.
- Forums
- ASX - By Stock
- CST
- annual report
annual report, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.41M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 226091 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 15337 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 226091 | 0.072 |
1 | 200000 | 0.071 |
3 | 230000 | 0.070 |
1 | 8475 | 0.059 |
1 | 13000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 15337 | 1 |
0.079 | 29850 | 1 |
0.080 | 32000 | 2 |
0.082 | 11000 | 1 |
0.084 | 8500 | 1 |
Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
Day chart unavailable